Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Movano (MOVE)
NASDAQ:MOVE
Holding MOVE?
Track your performance easily
Earnings Data
Report Date
Mar 19, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
-$0.97Last Year’s EPS
-$1.68Same Quarter Last Year
Based on 0 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Nov 14, 2024
|% Change Since: 51.02%
|Next Earnings Date:Mar 19, 2025
Earnings Call Sentiment|Positive
The earnings call highlighted several achievements, including successful sales of the Evie Rings, progress towards FDA clearance, and positive customer feedback. However, challenges such as stock price issues and financial concerns were also discussed. Overall, the sentiment leans slightly positive due to the company's forward momentum and strategic planning.Company Guidance
During the Movano Health Q3 2024 earnings call, the company provided guidance on several key metrics and strategic initiatives. Movano Health is optimistic about both its direct-to-consumer (D2C) and business-to-business (B2B) opportunities, emphasizing the EvieMed ring's anticipated FDA 510(k) clearance. The company has successfully shipped 339 Evie rings since resuming sales in September, achieving a 90%+ customer service approval score. It plans to capitalize on the upcoming Black Friday/Cyber Monday sales period with an entirely organic marketing strategy, resulting in efficient customer acquisition costs. Financially, Movano reported a Q3 operating loss of $7.4 million, down from $9.1 million in the previous year, with a cash position of $11.3 million as of September 30, 2024. The company continues to manage its cash burn carefully, which was approximately $5.6 million for the quarter. Additionally, Movano is exploring commercial opportunities with major pharmaceutical and healthcare partners, preparing for a pilot program in Q1 2025, and advancing its blood pressure and glucose monitoring technologies.Successful Sale of Evie Rings
Movano Health reported ongoing successful sales and fulfillment of Evie Rings following a back in-stock announcement on September 17.
Anticipated FDA Clearance for EvieMed Ring
Movano Health is in the final stages of the FDA 510(k) review process for the EvieMed ring, with positive progress towards clearance.
B2B Commercial Opportunities
The company is preparing to deliver its first B2B commercial opportunities with healthcare partners shortly after gaining FDA clearance.
Positive Customer Feedback
The company received a consistent 90%-plus customer service approval score, indicating a positive response to improvements in app features, operations, and customer service.
Efficient Customer Acquisition
Movano Health achieved an extremely efficient customer acquisition cost through organic marketing efforts.
Improved Financial Position
The company reported an operating loss of $7.4 million in Q3 2024, an improvement from $9.1 million in the previous year, with a cash reserve of $11.3 million.
---
MOVE Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
MOVE Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 14, 2024 | $3.52 | $3.21 | -8.81% |
| Aug 14, 2024 | $5.29 | $5.25 | -0.76% |
| May 15, 2024 | $7.04 | $6.60 | -6.25% |
| Apr 04, 2024 | $7.64 | $8.25 | +7.98% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Movano (MOVE) report earnings?
Movano (MOVE) is schdueled to report earning on Mar 19, 2025, TBA Not Confirmed.
What is Movano (MOVE) earnings time?
Movano (MOVE) earnings time is at Mar 19, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is MOVE EPS forecast?
MOVE EPS forecast for the fiscal quarter 2024 (Q4) is -$0.97.
---